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Background: Cardiopulmonary bypass (CPB) is a commonly used technique in cardiac surgery. CPB is however
associated with a strong induction of systemic inflammatory response syndrome (SIRS) which in conjunction with
ischemia and reperfusion may lead to multiple organ failure.
The aim of the study was to establish and characterize a CPB rat model incorporating deep hypothermic circulatory
arrest with a specific focus on the extent of the inflammatory reactions and organ damage as a groundwork for
novel therapeutics against SIRS and I/R induced organ injury.
Materials and methods: Male Wistar rats (n = 6) were cannulated for CPB, connected to a heart-lung-machine (HLM)
and cooled to a temperature of 16°C before they underwent 45 minutes of deep hypothermic circulatory arrest with
global ischaemia. Arrest was followed by rewarming and 60 minutes of reperfusion. Haemodynamic and vital parameters
were recorded throughout the CPB procedure. Only animals displaying sinus rhythm throughout reperfusion were utilized
for analysis. Rats were euthanized and tissue samples were harvested. Blood gas analysis was performed and
blood samples were taken. Induction of organ damage was examined by analysis of protein levels and phosphorylation
status of kinases and stress proteins. Results were compared to animals (n = 6) which did not undergo CPB.
Results: CPB induced leucocytosis and an increase of interleukin-6 and TNF-α plasma values indicating an inflammatory
response. Markers of tissue damage and dysfunction, such as troponin T, creatinine and AST were elevated. Phosphorylation
of STAT3 was induced in all examined organs. Activation of MAPK and induction of heat shock proteins occurred in an
organ-specific manner with most pronounced effects in heart, lungs and kidneys.
Conclusions: The presented CPB rat model shows the induction of SIRS and activation of specific signalling cascades. SIRS
seems not to be provoked during DHCA and is elicited mainly during reperfusion. This model might be suitable to test the
efficacy of therapeutics applied in major heart surgery with and without DHCA.
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Cardiopulmonary bypass (CPB) is a required technique
for major cardiovascular surgery. As a core component of
“on pump” surgery, extracorporeal circulation and oxy-
genation of blood is applied. Both processes take place in
a heart lung machine (HLM). The exposure of the blood* Correspondence: Payam.Akhyari@med.uni-duesseldorf.de
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unless otherwise stated.to artificial surfaces activates a variety of signalling
cascades which induce an inflammatory response, first
described as whole body inflammation syndrome [1].
Evolutionary needed for wound healing, under un-
favourable haemodynamic conditions as it can occur
during CPB, this may lead in 2-10% of all cases to a sys-
temic inflammatory response syndrome (SIRS), which
may further aggravate to multiple organ dysfunction
syndrome (MODS) [2,3]. SIRS is mediated primarily byLtd. This is an Open Access article distributed under the terms of the Creative
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inflammatory compensatory effects are promoted by the
adaptive immune response [4]. The “one hit model” pro-
poses that a severe SIRS alone is able to induce MODS
[5]. Induction of leucocytosis and secretion of the cyto-
kines TNF-α and IL-1β by activated monocytes and
macrophages are the first signs for SIRS followed by a
raise in IL-6 plasma level and a switch in Th1/Th2 cell bal-
ance [4,6]. The activation of the immune system is at least
partially responsible for collateral tissue damage observed
after CPB [7], but it has to be unlinked from the pure is-
chemia/reperfusion process. Ischaemia/reperfusion injur-
ies are caused to major tissues, primarily cardiovascular
and visceral organs and the central nervous system [8].
Those injuries are mediated by Ca2+-overload and reactive
oxygen species (ROS), which amongst others are gener-
ated by infiltrating macrophages [9,10] and mainly con-
tribute to morbidity and mortality after successful surgery
[11]. The extent of I/R-induced tissue damage is not only
restricted to the cardiovascular system but also affects the
kidneys, the respiratory system, the liver, the central ner-
vous system and the intestine [12]. Until now, treatment
of I/R damage on clinical scale is limited to an increase of
fibrinolysis which might indirectly decrease the postopera-
tive inflammatory response [13], whereas therapies that
directly suppress I/R damage are lacking. One approach
would be to counteract the induction of SIRS following
the “one hit model”. For this purpose, we established a rat
model which relies on preceding experiments of Jungwirth
et al. [14].
Following the van’t Hoff equation, lowering the
temperature by 10°C decreases the metabolic rate of
the myocardium by 50%. In accordance with this con-
cept known since the 19th century, hypothermia was
successfully introduced into cardiac surgery for myo-
cardial protection by Lewis and Taufic in 1953 [15]. Deep
hypothermic circulatory Arrest (DHCA) has proven to be
an effective mean of ischemia protection not only for the
cardiovascular system but even more for the cerebrospinal
and renal system [16].
Extending the aforementioned models, we elucidated
biochemical events leading to the systemic inflammatory
response associated with CPB and DHCA in multiple or-
gans in a clinically relevant approach. We hypothesized
that SIRS is not induced by DHCA but it is mainly af-
fected by the following reperfusion, in which organ dam-
age becomes apparent. The here presented model enabled
us to determine common hemodynamic parameters and
to assess a variety of circulating surrogate markers for the
inflammatory response [17] as well as early alterations in
protein levels and/or phosphorylation of MAPKs (Mito-
gen activated protein kinase), STAT3 (Signal transducer
and activator of transcription) and Heat-Shock-Proteins,
e.g. heme oxygenase 1 (HO-1) and heat-shock-protein70 (HSP70), on the organ level. Elevated biosynthesis and/
or activation of these proteins are triggered by I/R-induced
inflammatory signals in the heart and other organs. They
mediate key signalling events following I/R and the extent
of their induction/activation determines the outcome of
tissue adaption and inflammation after CPB and DHCA
[10,18,19]. MAPK, STAT3, HO-1 and HSP70 are media-
tors of the I/R- and cytokine-induced organ damage and
also potential targets for selective inhibitors or activators
which may supress SIRS [2,19-21]. Therefore we consid-
ered it as our primary goal to determine the organ-specific
signalling status in target organs possibly affected by
MODS. Based on information on hemodynamic and
metabolic parameters combined with molecular I/R-
induced alterations in various organs, the presented
rat model appears to be a suitable experimental plat-
form for the in-depth investigation of SIRS and associ-
ated signalling events. This may contribute to improve
the outcome of patients undergoing CPB and DHCA
in cardiac surgery.
Methods
All reagents had analytical grade purity and were ac-
quired from Sigma-Aldrich if not stated otherwise.
Animals
This study was approved by the local authority LANUV
(Landesamt für Natur, Umwelt und Verbraucherschutz
NRW) and carried out in accordance with the German
guidelines of laboratory animal care.
All experiments were performed with male Wistar rats
weighing between 500 and 600 g, which were purchased
from Janvier Breeding Center (Le Genest St. Isle, France).
They were housed at the Institute of Animal Experiments of
the Heinrich-Heine-University in stables with a temperature
of 22°C, a relative humidity of 55% and a day/night cycle of
12/12 hours, with food and water ad libitum. Rats were
randomly divided into two groups. The first group was
subjected to an operative procedure and exposed to I/R
(I/R; n = 6), whereas the second group consisted of healthy
animals that were not exposed to I/R (H; n = 6). Healthy
animals were not cannulated, but directly transcardially
perfused to guarantee best organ preservation for western
blot analysis.
Ischaemia/reperfusion model
This model was established by Jungwirth et al. and
adopted for our project with modifications as described
below. Rats of the I/R-group were treated as follows:
After anaesthetisation in an exsiccator rats were endo-
tracheally intubated with a 14G cannula (Vasofix Safety,
Braun, Melsungen, Germany) and mechanically venti-
lated (70 strokes/min., 45% O2/balance N2, PaCO2 of
35-45 mm Hg). During subsequent surgical preparation
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Monitoring was maintained using a rectal temperature
sensor, an oxygen saturation-clip at the right hindpaw
and continuous electrocardiogram (ECG). The median
sacral artery was cannulated with a 20G cannula (Vasofix
Safety, Braun, Melsungen, Germany), which served as the
arterial inflow cannula for the CPB circuit. Systemic ad-
ministration of 200 IU heparin and 0.5 μg of fentanyl
followed the placement of the catheter. Mean arterial
blood pressure (MAP) was monitored via cannulation of
the femoral artery. A 4.5 multi-orifice cannula was
pleaded into the right atrium through the right exter-
nal jugular vein and served as the venous outflow. The
custom made heart lung machine circuit consisted of a
venous reservoir, a roller pump and an oxygenator,
which was built of two plexiglas plates surrounding a
disposable three layer hollow fiber membrane with a gas
exchange area of 558 cm2 (M. Humbs, Valley, Germany). A
scheme of the CPB circuit is shown in Additional file 1:
Figure S1 of the supplementary data. The CPB circuit was
primed with 15 ml of 6% hydroxyethyl starch (HAES 6%,
KabiPac, Fresenius Kabi GmbH, Bad Homburg, Germany).
Through the venous catheter blood of the jugular vein flew
into the venous reservoir leading the blood through the
peristaltic pump into the membrane oxygenator where the
gas exchange occurred. From there on the enriched blood
returned to the animal via the arterial inflow cannula.
To secure a uniform time frame for the cannulation in
all experiments, 90 minutes after placing the arterial
catheter the rats were connected to the HLM, and CPB was
induced. The flow rate started with 160 to 180/kg−1/min−1
(which is similar to the physiologic cardiac output of the rat)
and was gradually decreased or increased by half during the
cooling and rewarming period, respectively. During the CPB
fentanyl (0.5 μl/h) and cisartracurium (Nimbex® 0.8 mg/h,
GlaxoSmithKline GmbH & Co. KG, München, Germany)
were administered over the venous reservoir and the
rats were ventilated with 10 strokes/min. To secure the
perfusion of the organs the MAP was maintained above
40 mmHg via small doses of norepinephrinhydrochlor-
ide (0.02 mg/ml Arterenol®, Sanofi-Aventis, Frankfurt,
Germany), if necessary. Moreover, CO2, bicarbonate
(NaBiC 8.4%, Braun, Melsungen, Germany) or trometamol
(Tris 36.34%, Braun, Melsungen, Germany) were adminis-
tered to adjust for pH fluctuations (α-stat blood gas re-
gime), if required. No blood transfusions were given.
Systemic cooling was carried out by a heat exchanger
and additional ice bags were used for topical cooling to
achieve a rectal temperature of 16°C within 30 minutes.
At a rectal temperature of 16°C CPB, anaesthesia and
ventilation were interrupted and the rats were exposed
to 45 minutes of DHCA to expose all organs to ischae-
mia. After 45 minutes of DHCA the CPB was re-started
and the rats were slowly rewarmed to a rectal temperatureof at least 35.5°C within 40 minutes. An infrared lamp was
employed additionally, if required. By reaching 35.5°C the
rats were re-perfused for further 60 minutes before CPB
was terminated and organ harvesting took place. A
schematic illustration of the experimental time and
temperature flow is shown in Figure 1.
Harvesting of samples
Before the start of CPB (T1), after 25 minutes of cooling
(T2), during rewarming at a rectal temperature of 20°C
(T3) and 35°C (T4) and after 60 minutes of reperfusion
(T5) arterial blood gas analyses were performed and the
vital signs were documented. Additionally, blood sam-
ples were taken at T1, T2 and T5. They were transferred
to heparin-containing tubes and kept at room temperature
for 30 minutes to allow coagulation before centrifuging
at 4000g. Plasma aliquots were snap-frozen and stored
at -80°C.
For harvesting of organs, animals were perfused with
NaCl and organs were removed in the following order:
heart, lung, liver, and kidney. All organs were immedi-
ately snap-frozen in liquid nitrogen for subsequent mo-
lecular analysis.
In order to illustrate the study design and the time
points taken for data collection throughout the experi-
ment, the experimental time and temperature flow is
given in a scheme (Figure 1). The experimental setup
was designed to mimic standard procedures in the clin-
ical scenario of cardiothoracic surgery using CPB and
DHCA. Similarly, time points of blood sampling have
been set to meet critical transition points during CPB.
After an initial period of establishment, six animals of
the I/R group were evaluated.
Healthy animals (H) were anaesthetised by injection of
pentobarbital. Blood samples were taken by puncture of
the left ventricle after anaesthetisation and the rats were
perfused with NaCl for 3-5 minutes until organs could
be harvested. Animals in the H group did not undergo
any further surgical treatment.
Analysis of metabolic parameters in plasma samples
Using blood plasma samples taken before CPB (T1),
after 25 minutes of cooling (T2) and after 60 minutes
of reperfusion (T5) following parameters were deter-
mined by the Central Institute of Clinical Chemistry
and Laboratory Medicine of the University Hospital
Duesseldorf: lactate, urea, aspartate transaminase (AST),
alanine transaminase (ALT), lactate dehydrogenase (LDH),
creatinine and potassium. These parameters were mea-
sured spectrophotometrically using commercially available
standard Roche-Hitachi methodology (Roche Diagnostics
GmbH, Mannheim, Germany). Plasma interleukin-6
(IL-6) and TNF-α levels were determined using an
ELISA (Gen-Probe DIACLONE SAS, France) according
Figure 1 Schematic illustration of the experimental time and temperature flow. T1-T5 represent predefined time points for blood sampling.
T1 = before the start of CPB; T2 = after 25 minutes of cooling; T3 = at 20°C of rewarming; T4 = at 35°C of rewarming; T5 = after 60 minutes
of reperfusion.
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nin, c-reactive protein (CRP), creatine kinase (CK) and
MB isoform of CK (CK-MB) were determined in plasma
samples by a partner laboratory specialised in clinical
diagnostics (Laboklin; Bad Kissingen, Germany) using
ELISAs according to the manufacturer’s instructions.Analysis of molecular parameters in tissue samples
Immunoblot analysis of proteins in tissue samples was per-
formed as previously described [22]. Briefly, a portion of
each tissue was lysed in M-Per Mammalian Protein Extrac-
tion Reagent (Thermo Scientific Pierce, Rockford, IL) con-
taining protease inhibitors (Merck, Darmstadt, Germany)
and phosphatase inhibitors (Sigma-Aldrich, Taufkirchen,
Germany). The protein content of the lysates was measured
by DC Protein assay (Bio-Rad, München, Germany) with
bovine serum albumin as standard. Lysates were boiled in
Laemmli-loading-buffer and loaded either onto 10% or 14%
SDS-PAGE gels. After electrophoresis the gels were trans-
ferred to PVDF-membranes (Hybond-P, General Electrics
Healthcare, München, Germany). Equal loading was con-
trolled by Ponceau S staining. After blocking the membranes
with 5% non-fat dry milk for 60 minutes, the following pri-
mary antibodies were applied: anti-phospho-ERK1/2, anti-
total-ERK1/2, anti-phospho-p38 MAPK, anti-total-p38
MAPK, anti-phospho- JNK, anti-total-JNK, anti-phospho-
STAT3, anti-total-STAT3, pan-Cadherin (all obtained
from Cell Signaling Technology, Beverly, MA). Moreover,anti-HSP 70 (StressMarq Biosciences Inc., Victoria,
Canada), anti-HO-1 (Epitomics, Burlingame, California),
and anti-β-actin (Sigma-Aldrich, Taufkirchen, Germany)
were used. As secondary antibodies, HRP-coupled anti-
rabbit IgG (Dianova, Hamburg, Germany) and anti-mouse
IgG (Thermo Scientific Pierce, Rockford, IL) antibodies
were used. As chemoluminiscence reagents Supersignal
Pico and Femto (Thermo Scientific Pierce, Rockford, IL)
were used. Signals were detected on x-ray films (GE
healthcare, Pittsburgh, PA).Statistical analysis
One-way Anova for repeated measurement was used to
analyse changes at different time points (T1, T2 and T5)
followed by a post hoc Tukey test. Nonparametrical ana-
lysis by Friedman Test gave similar results. Analysis be-
tween healthy animals and T1 of the I/R group was
done by Student’s t-Test. All analyses were performed by
Graphpad Prism 5.0.Results
Haemodynamic parameters
Table 1 displays the haemodynamic and physiological
parameters of the animals in the I/R group. CPB priming
with 15 ml 6% hydroxyethyl starch resulted in an ex-
pected decrease of haemoglobin concentration from 12.3
(±0.4) g/dl before CPB to 4.5 (±1.0) g/dl at the end of
the entire experiment and a decrease of the haematocrit
Table 1 Haemodynamic and physiological parameters
T1 T2 T3 T4 T5
Haematocrit (%) 35.8 (±1.9) 17.3 (±1.0) 14.3 (±2.4) 11.9 (±3.4) 9.4 (±2.6)
Haemoglobin (g/dl) 12.3 (±0.4) 6.4 (±0.3) 5.9 (±0.5) 5.7 (±0.6) 4.5 (±1.0)
WBC (x103/mm3) 5.0 (±2.1) 1.9 (±0.7) 1.7 (±0.7) 3.1 (±0.7) 2.7 (±0.9)
WBC/Hct (x103/mm3) 5.0 (±2.1) 3.7 (±1.3) 3.8 (±1.5) 11.9 (±3.9) 24.2 (±14.4)
WBC/Hct ratio 1.0 (±0.0) 1.2 (±0.5) 1.0 (±0.3) 8.1 (±3.1) 11.9 (±7.2)
Heart rate (bpm) 294.7 (±4.9) 44.7 (±10.2) 82.5 (±27.7) 208.0 (±26.7) 228.3 (±52.2)
MAP (mmHg) 60.5 (±5.7) 53.7 (±7.4) 64.8 (±9.4) 51.8 (±4.9) 59.7 (±3.5)
sO2 (%) 95.8 (±0.7) 95.3 (±3.8) 96.0 (±0.0) 100.0 (±0.0) 87.5 (±6.5)
Temperature (°C) 36.1 (±0.3) 17.5 (±0.7) 20.0 (±0.0) 35.0 (±0.0) 36.4 (±0.4)
pO2 (mmHg) 48.2 (±0.9) 47.7 (±3.3) 47.3 (±5.2) 48.8 (±4.4) 44.4 (±4.8)
pCO2 (mmHg) 2.7 (±0.4) 0.3 (±0.0) 0.5 (±0.2) 1.0 (±0.2) 1.1 (±0.3)
pH 7.27 (±0.03) 7.09 (±0.19) 7.39 (±0.21) 7.33 (±0.10) 7.35 (±0.07)
BE (mmol/L) −5.6 (±1.12) −7.7 (±3.4) −12.7 (±2.4) −12.5 (±3.2) −10.0 (±3.1)
HCO3 (mmol/L) 20.7 (±1.2) 21.8 (±0.9) 12.5 (±1.5) 13.8 (±3.4) 15.2 (±3.0)
At defined time points before CPB (T1), after 25 minutes of cooling (T2), at 20°C during the rewarming (T3), at 35°C during the rewarming (T4) and after 60
minutes of reperfusion (T5) haemodynamic and physiological parameters are measured. WBC = white blood cells; Hct = haematocrit; WBC/Hct ratio =WBC count as
a value normalized to the respective Hct and normalized to the start values; bpm = beats per minute; MAP =mean arterial pressure; sO2 = arterial oxygen
saturation; pO2 = partial pressure of oxygen; pCO2 = partial pressure of carbon dioxide; BE = base excess; HCO3 = standard bicarbonate. Data represent
means ± SEM of six independent experiments.
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of the experiment.
Furthermore, a leucocytosis during the rewarming and
reperfusion period was observed. Considering the haemo-
dilution by the CPB priming, the leucocyte numbers were
calculated in relation to the haematocrit to obtain com-
parable values. As the reference range of the leucocytes
varies from 3 to 15 × 103/mm3, for each animal the leuco-
cyte count was normalised to the individual start value.
Regarding the MAP, no significant differences were
observed between the different time points throughoutTable 2 Clinical plasma parameters at defined timepoints
Healthy Animals T1 T2
Lactate (mmol/l) 6.22 (±1.22) 2.422 (±0.20) 5.8
Troponin (pg/ml) 204.32 (±1.22) 191.31 (±9.75) 327
CK-MB (ng/ml) < 0.1 0.50 (±0.28) 0.3
ALT (U/l) 43.00 (±3.73) 26.25 (±5.33) 14.
AST (U/l) 90.00 (±14.16) 43.2 (±10.2) 28.
Urea (mmol/L) 4.42 (±0.10) 4.8 (±0.21) 5.3
LDH (U/l) 287.50 (±88.56) 134.5 (±100.47) 154
Creatinine (μmol/L) 18.0 (±0.22) 19.33 (±1.54) 51.
CRP (mg/ml) 0.44 (±0.13) 0.46 (±0.08) 0.1
Potassium (mmol/l) 3.03 (±0.47) 3.02 (±0.22) 2.9
Calcium (mmol/l) 1.81 (±0.03) 1.69 (±0.09) 1.6
Values were measured in plasma of healthy animals and of I/R animals before CPB
CK = Creatine kinase; CK-MB =MB isoform of CK; AST = aspartate transaminase; ALT
n.a. = not applicable. Data are the means ± SEM of six independent experiments. S
comparison analysis. Overall significance is marked by one asterisk (*) if p < 0.0
§(T1 vs. T2), $(T1 vs. T5) and #(T2 vs. T5).the operation. Heart rate and temperature changes were
in accordance with the gradual alternation of the flow rate
during the cooling and rewarming period. Blood pH values
and partial pressures remained stable or were corrected.
Clinical biochemistry
The plasma samples of the healthy animals and of the
time points T1, T2 and T5 were analysed for crucial
clinical blood parameters as summarized in Table 2.
Plasma AST, creatinine, troponin and potassium levels
are exemplarily shown in Figure 2.T5 Healthy-T1 T1-T5
3 (±1.04) 36.4 (±10.53) 0.03* 0.004**$#
.02 (±41.7) 286.34 (±36.1) 0.228 0.026*§
4 (±0.24) 0.84 (±0.69) n.a. 0.733
6 (±0.5.76) 433.5 (±252.3) 0.03* 0.101
2 (±7.14) 573.5 (±184.8) 0.023* 0.004**$#
8 (±0.92) 6.38 (±1) 0.127 0.390
.50 (±56.6) 3154 (±1328.98) 0.240 0.080
00 (±2.02) 64.50 (±13.53) 0.412 <0.0001**§$#
4 (±0.03) 0.17 (±0.07) 0.922 0.006**§$
4 (±0.11) 6.26 (±1.10) 0.980 0.008**$#
2 (±0.06) 1.77 (±0.21) 0.199 0.682
(T1), after 25 minutes of cooling (T2) and after 60 minutes of reperfusion (T5).
= alanine transaminase; LDH = lactate dehydrogenase; CRP = c-reactive protein;
ignificant differences were measured by ANOVA with Tukey test multiple
5 and by two asterisks (**) if p < 0.01. Intra-group significance is marked as
Figure 2 Changes in selected clinical biochemistry parameters. AST (A), creatinine (B), troponin (C) and potassium (D) were measured in
plasma of healthy rats and of I/R animals before CPB (T1), after 25 minutes of cooling (T2) and after 60 minutes of reperfusion (T5). AST activity is
given in units per liter (U/l). Creatinine concentration is presented in mg/dl. Troponin is given in pg/ml. Potassium concentration is presented in
mg/dl. Data are the means ± SEM of six independent experiments. Significant differences by one-way ANOVA with Tukey-test post analysis is
marked by one asterisk (*) for p < 0.05 and by two asterisks (**) for p < 0.01. For inter-group differences see Table 2.
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after cooling but significantly increased after reperfusion
(Figure 2A) as compared to healthy animals and T1.
Plasma ALT activity showed similar tendencies but these
changes did not reach a statistical significance despite a
clear trend (Table 2). In addition, a strong increase in
Plasma LDH activity was observed after reperfusion.
Compared to healthy animals and to T1 creatinine was
significantly increased both, after cooling and reperfu-
sion but remained within the reference range (Figure 2B).
Urea was also increased after the cooling and reperfu-
sion, even though it exceeded the reference range only
slightly (Table 2). Levels of high sensitive troponin were ex-
plicitly increased after 25 minutes of cooling as compared tohealthy animals and T1 (Figure 2C). Plasma concentrations
of most electrolytes did not change during I/R with the ex-
ception of potassium that decreased after 25 minutes of
cooling whereas it increased significantly after 60 minutes of
reperfusion (Figure 2D). CRP levels were constant between
healthy animals and T1. During CPB however, CRP levels
decreased significantly at T2 and T5, possibly due to the ini-
tial priming of the system with HAES. CK-MB levels were
decreased after cooling but increased after reperfusion if
compared to levels of healthy animals and T1 (Table 2).
Plasma lactate levels showed a slight increase after cooling
but an explicit increase after 60 minutes of reperfusion as
shown in Table 2. Other clinical biochemistry parameters
(sodium, chloride, magnesium, creatine kinase in plasma of
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supplementary data.
Increase in IL-6 and TNF-α plasma levels after
reperfusion
Increased levels of the pro-inflammatory cytokines TNF-
α and IL-6 can be observed during CPB.
IL-6 increase is associated with reperfusion and in-
duces a variety of downstream events, e.g. cardioprotec-
tion by JAK/STAT signalling during CPB. We therefore
determined the plasma IL-6 and TNF-α levels at T1, T2
and T5. Rewarming and reperfusion (T5) following
DHCA led to a dramatic increase of IL-6 in all ani-
mals, causing significantly elevated values as compared
to time points prior to DHCA or as compared to
values observed in healthy animals (Figure 3A). Note-
worthy, IL-6-levels of the T1 and T2 samples all lay
under the detection level (according to the manufac-
turer at 19 pg/ml). TNF-α-levels were also significantly
elevated after reperfusion as compared to prior time points
and to healthy animals. In contrast to the IL-6-levels, TNF-
α-levels were already elevated after 25 minutes of cooling
(Figure 3B). Therewith the present study could demon-
strate that I/R injury as applied in the presented model
leads to an increase of the pro-inflammatory cytokines IL-6
and TNF-α.
I/R-induced alterations in expression and phosphorylation
status of intracellular signal mediators and heat shock
proteins
Key intracellular players of the I/R related signal trans-
duction were evaluated to further explore the validity of
the presented model as a tool for scientific work on I/R.Figure 3 Plasma IL-6 and TNF-α Levels. IL-6 (A) and TNF-α (B) were meas
of cooling (T2) and after 60 minutes of reperfusion (T3). Values are given as pg/
was determined by one way ANOVA with Tukey-test post analysis. A: T5
T5-values were significantly higher than T1- and basal animal-values.I/R modulates the kinases ERK1/2, p38 and JNK by al-
tering their site-specific phosphorylation. Consequently,
we analysed changes in phosphorylation of ERK1/2 at
Y202/T204, of p38 at T180/182 and of JNK at T183/Y185
after hypothermic global ischaemia and normothermic re-
perfusion. Furthermore, the expression of the heat shock
proteins HSP-70 and HO-1, which are induced immedi-
ately after ischaemia as organ protective mechanisms, was
analysed. As a mediator of cellular inflammatory response,
phosphorylation of the transcription factor STAT3 at Y705,
which among others is induced by IL-6, was assessed [21].
We chose to analyse tissue samples from the heart, the
lung, the liver and the kidney to demonstrate the sys-
temic effect of I/R associated with the presented model.
As a result of I/R, organ-specific phosphorylation and
expression patterns could be detected, which were dis-
tinct for each of the investigated organs and will be dis-
cussed in the following paragraphs individually in detail.
As a control for uniform loading and protein levels,
pan-cadherin was used because it gave better results
than β-actin and α-Tubulin. A brief summary is pre-
sented in Table 3. Representative blots for ERK1/2,
HSP-70 and STAT3 are displayed in Figure 4A-B. The
complete western blot results are shown in Additional
file 3: Figure S2 and in Additional file 4: Figure S3 of
the supplementary data.
Heart
I/R induced a significant increase in the phosphorylation of
cardiac ERK1/2 as compared to healthy animals (Figure 4A).
Similar results have been reported for rat models of ischae-
mic preconditioning and were attributed to the transloca-
tion of the signal mediator protein kinase Cε from theured in healthy animals and in I/R animals before CPB (T1), after 35 minutes
ml. Data are presented as mean ± SEM of six animals. Significance
-values were significantly higher than T2-, T1- and basal animal-values; B:
Table 3 Compilation of the observed I/R-induced changes
in protein expression or phosphorylation in different
organs
Heart Lung Liver Kidney
p-STAT3 (↑) (↑) (↑) (↑)
p-Erk1/2 ↑ (↓) (↓) ↓
p-JNK (↑) (↓) - (↑)
p-p38 (↓) ↓ ↓ -
HSP-70 (↑) ↓ - (↑)
HO-1 - (↓) - ↓
Protein expression in the I/R group is compared with healthy animals. P =
phosphorylation; ↑ = increase; ↓ = decrease; (↑) = upward trend; (↓) = downward
trend; - = no difference/not detectable.
Engels et al. Journal of Inflammation 2014, 11:26 Page 8 of 11
http://www.journal-inflammation.com/content/11/1/26cytosol to mitochondria [23]. Additionally, the involvement
of cytokines in the present study is further indicated by in-
creased STAT3 phosphorylation in 4 of 5 I/R animals in
contrast to the healthy animals, where no phosphorylation
was observed. However, when JNK was analysed, as a con-
sequence of I/R no change could be detected in both, the
total protein expression and the phosphorylation status.
Furthermore, in three out of five I/R animals we observed a
decrease of p38 MAPK phosphorylation, which may be due
to the long reperfusion time. Similar effects have beenFigure 4 Selected representative immunoblots of heart (A) and live
(A) and liver (B) tissue of animals undergoing global hypothermic ische
I/R (Healthy).previously observed in other rat models of isolated cardiac
I/R [24]. Equally, three out of five I/R animals showed a
considerable increase of HSP-70 protein expression
(Figure 4A), matching the previously reported observa-
tions that HSP-70 expression is increased in myocar-
dial infarction and I/R, potentially as a protective
response. HO-1 protein expression did not differ be-
tween the two groups.
Lung
As stated above, an increase of STAT3 protein phos-
phorylation was recognised in all analysed organs, in-
cluding the lungs. Moreover, I/R induced a decrease of
phosphorylated ERK1/2 and total ERK1/2 expression in
comparison to healthy animals. Similarly, a decrease of
both, phospho-JNK and total-JNK signals was detected.
A decrease of phosphorylation was also visible on p38
MAPK. Based on existing reports I/R is expected to acti-
vate MAP-kinases. However, this type of regulation did
not prove to be consistently predominant throughout all
organs analysed in this study. Major reasons could be
the dilution of WBC by the necessary hydroxyethyl
starch during CPB as well as the time dependent decrease
of phosphorylation of key regulator proteins after their initialr (B). Results of protein expression analysis by western blot in heart
mia and reperfusion (I/R) as compared to healthy animals without
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was observed after I/R as compared with healthy animals.
Additionally, four of five rats undergoing I/R showed a de-
crease of HO-1 protein expression. The dilution of alveolar
white blood cells, having high content of HSP-70 and HO-1,
might lead to reduced protein detection [26].
Liver
When liver tissue was analysed, an increase of STAT3
phosphorylation in comparison to healthy animals was
detected in animals prone to I/R (Figure 4B). Further-
more, similar to the results obtained for the lung a de-
crease of ERK1/2 MAPK phosphorylation was detected
in the liver of I/R animals. JNK protein expression and
phosphorylation did not differ between the two groups.
The missing induction may imply that JNK does not
contribute to I/R-associated injury nor to protective ef-
fects in the settings of this model, while under different
conditions an increased JNK-activation is protective [27].
In our set-up I/R induced a strong decrease of the phos-
phorylation of hepatic p38 MAPK as compared with
healthy animals (Figure 4B). No apparent differences in
HSP-70 and HO-1 protein expression were observed be-
tween I/R and healthy animals.
Kidney
In the kidneys, I/R also induced an increase of STAT3
protein expression. In four of five I/R animals the phos-
phorylation of ERK1/2 and p38 MAPK was decreased.
However, there was no significant difference in p38
MAPK total protein expression detectable between the
two groups. Concerning ERK1/2, the activation can be
attributed to an activation of the STAT3 pathway. Fur-
thermore, an increase of phosphorylation of JNK com-
pared to healthy animals was observed. A consistent
trend was observed with the protein expression of HSP-
70, an accepted marker for renal I/R injury, which was
demonstrated to be slightly elevated [22]. In contrast, a
decrease in protein expression of HO-1 was detected
which was not expected to occur after I/R. However, this
finding may be attributed to the steady decline of HO-1
expression along the inflammatory response and in-
creased heme release during CPB [28,23]. Interestingly,
renal damage is not always observed in humans under-
going CPB [24]. Possibly, in our rat model renal damage
was not accentuated, explaining the faint changes on
phosphorylation and protein expression observed [29,30].
Discussion
Ischaemia/reperfusion (I/R) injury contributes to the de-
velopment of SIRS which enhances morbidity and mor-
tality after surgery requiring CPB and DHCA. The
involved mechanisms and molecular pathways are not
completely understood, yet. Thus, it is important toprovide a suitable animal model which is capable of
mimicking signalling events of I/R and inflammation in
humans. Based on previously published animal models it
therefore was the aim of this study to establish an appro-
priate animal model, giving special attention to SIRS asso-
ciated with I/R in multiple organs.
The observed alterations of most of the analysed blood
parameters showed, that they underlie an influence by
CPB. The above mentioned increase in plasma AST ac-
tivity is expected to occur after reperfusion, as it repre-
sents a marker for liver, skeletal and cardiac muscle
damage. The observed decrease in AST activity during
the cooling period might be due to haemodilution asso-
ciated with CPB.
Although the increase of creatinine remained within
the reference range, the course of this parameter indi-
cates an impaired renal function developing throughout
the experiment, possibly caused by I/R-induced renal tis-
sue damage as reported [14].
The increased levels of cardiac troponin, CK-MB and
LDH were in accordance with findings of other groups
and have been reported in humans after CPB and I/R, re-
spectively as compared to the levels before surgery [15].
The increase of IL-6 and TNF-α during reperfusion is
associated with SIRS and may induce JAK/STAT signal-
ling during CPB. The dramatic increase of IL-6 and
TNF-α after the reperfusion is correlated with a strong
leucocytosis. At the same time points CRP levels remained
low, matching very well the conditions of a beginning
SIRS for the intra-operative time frame we decided to in-
vestigate. CRP as a marker of the complement system ac-
tivation is elevated only after one or two days after surgery
[31,32]. The present study could demonstrate that I/R in-
jury as applied in the described model leads to an increase
of the pro-inflammatory cytokines IL-6 and TNF-α, which
can activate intracellular signalling [17]. For the interpret-
ation of the above data it must be considered that we ob-
served haemolysis in the reperfusion blood samples and
that haemolysis can cause an increase of LDH, AST, ALT,
potassium and CK-levels [16].
As a further result of SIRS and I/R organ-specific
phosphorylation and expression patterns of stress pro-
teins could be detected. As assessed by STAT3 phos-
phorylation, an inflammatory response was observed in
all organs as expected [21]. Those findings are in agree-
ment with the increased number of leucocytes and the
higher IL-6 plasma levels in I/R-animals after reperfu-
sion. Previous to the presented experiments and based
on literature a number of I/R-induced alternations of the
protein expression level and protein phosphorylation
level were anticipated, particularly involving MAPK acti-
vation as well as heat shock protein induction. However,
following our ‘cardiocentric’ and clinically derived approach
those expected changes were not entirely confirmed by the
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present for all of the detected proteins in all organs. How-
ever, an organ-specific pattern of intracellular response
to I/R has already been suggested, e.g. demonstrating
divergent results for the heart as opposed to other or-
gans [24,33]. Especially JNK phosphorylation pattern
were dissimilar for most organs, but contradictory re-
sults have been reported, indicating that JNK activa-
tion may differ in I/R injury [27,34]. One of the major
reasons for divergence in I/R-induced signalling events
may be the extent of I/R that actually acts on the indi-
vidual organs, but also the organ-inherent tolerance to
transient ischemic periods. In case of the heart, the
level of induced cardioplegia as applied in different
models may represent an explanation for the differ-
ences between our results and those of other studies.
In contrast, abnormal calcium levels can be excluded
in our set-up as a trigger for kinase activation and heat
shock protein induction, because no difference was no-
ticed in calcium serum levels (see Table 2).
In the presented work we have chosen to undertake a
final measurement of protein expression and phosphor-
ylation at the end of the complete I/R procedure. Al-
though this approach has proven valid to demonstrate
various aspects of an ideal SIRS-I/R model, it yet may
have led to a simplified picture of events occurring over
the time period of the entire experiment. Likewise, the one-
point detection of the read-out measures may have caused
a systematic masking of kinase phosphorylation kinetics
that are known to represent a highly time dependent transi-
ent effect [18,24]. Furthermore, the truly SIRS-dependent
molecular effects have to be dissected from other I/R vari-
ables by ongoing experiments. Thus, in following studies
the influence of hypothermia, reperfusion and haemolysis
on I/R and SIRS triggered signalling events shall be further
analysed.
The following limitations may be applied to our study.
Cardiac arrest was achieved by deep hypothermia, no
cardioplegic solution was applied. This was done on pur-
pose to exclude signalling induced by excessive applica-
tion of potassium. Since the focus of the study centers
on early signalling events which may protect from or in-
duce organ damage, we did not investigate angiopathic
and apoptotic changes induced by I/R. Moreover the
transition from SIRS to MODS was not aim of this study.
These points will be considered in ongoing studies.
Conclusion
We established a CPB rat model that can reproduce com-
mon pathophysiological and molecular alterations that are
associated with the induction of SIRS and the activation of
specific signalling cascades. This standardised model may
serve as a tool to evaluate the extent of the inflammatory
reactions and organ damage associated with I/R and SIRSand to investigate the potential of novel therapeutics in a
preclinical model. It might be suitable to test the efficacy
of immunosuppressive therapeutics applied in major heart
surgery using CPB with and without DHCA. The contri-
bution of the different aspects of CPB might be investi-
gated in detail, as the role of oxidative stress and
inflammation might be further discriminated by ana-
lysing the involved molecular pathways.
Additional files
Additional file 1: Figure S1. Schematic representation of the applied
CPB circuit.
Additional file 2: Table S1. Additional clinical biochemistry parameters
(sodium, chloride, magnesium and creatine kinase levels in plasma of I/R
animals at times T1, T2 and T5).
Additional file 3: Figure S2. I/R-induced changes in protein expression
or phosphorylation in heart and lungs of rats, as analysed by immunoblotting.
Additional file 4: Figure S3. I/R-induced changes in protein expression
or phosphorylation in liver and kidneys of rats, as analysed by
immunoblotting.
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